Physician profile
Jun Lu
NPI 1417099128
$19,816.76
in general payments reported to CMS, 2019-2025
18 companies · $19K in 2025
The $19K reported for 2025 was more than what 94% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $38.52 · 2021: $137 · 2022: $371 · 2024: $147 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,561 · Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,882.50 |
| Travel and Lodging | $1,561.09 |
| Food and Beverage | $652.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $14,770.28 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $3,990.00 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $207.04 | 2019-2022 | |
| Leo Pharma INC. | $167.31 | 2021-2025 | |
| Abbvie INC. | $153.32 | 2019-2022 | |
| Genzyme Corporation | $142.99 | 2021-2024 | |
| Janssen Biotech, INC. | $99.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $64.41 | 2022 | |
| Pfizer INC. | $47.77 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $43.31 | 2022 | |
| Sun Pharmaceutical Industries INC. | $35.64 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $34.85 | 2022 | |
| Galderma Laboratories, L.P. | $25.92 | 2025 | Nemluvio |
| Organogenesis INC. | $17.57 | 2021 | |
| Lilly USA, LLC | $17.35 | 2025 | Taltz, Ebglyss |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.